コンテンツへスキップ
- Natsumeda M. Predicting BRAF V600E variants: yet another new method. Transl Cancer Res, 11(12):4228-4230,2022.
- Mouri Y, Natsumeda M, Okubo N, Sato T, Saito T, Kohei S, Yamada S, On J, Tsukamoto Y, Okada M, Oishi M, Eda T, Murai J, Shimizu H, Kakita A, Fujii Y. Successful treatment of acute uric acid nephropathy with rasburicase in a primary central nervous system lymphoma patient showing dramatic response to methotrexate – case report. J Clin Med,11(19):5548, 2022.
- Sasaki T, Watanabe J, He X, Katagi H, Suri A, Ishi Y, Abe K, Natsumeda M, Frey WH, Zhang P, Hashizume R. Intranasal delivery of nanoliposomal SN-38 for the treatment of diffuse midline glioma. J Neurosurg, 138(6):1570-1579, 2022.
- Natsumeda M, Matsuzawa H, Watanabe M, Motohashi K, Gabdulkhaev R, Tsukamoto Y, Kanemaru Y, Watanabe J, Ogura R, Okada M, Kurabe S, Okamoto K, Kakita A, Igarashi H, Fujii Y. Susceptibility-weighted imaging by 7-tesla magnetic resonance imaging for the microscopic imaging diagnosis of astrocytic and oligodendroglial tumors. AJNR Am J Neuroradiol, 43(11):1575-1581, 2022.
- Watanabe T, Noto S, Natsumeda M, Kimura S, Tabata S, Ikarashi F, Takano M, Tsukamoto Y, Oishi M. Characteristics of health-related quality of life and related factors in patients with brain tumors treated with rehabilitation therapy. J Patient Rep Outcomes, 6(1):94, 2022.
- Sato T, Hiraishi T, Tada M, Natsumeda M, On J, Sasaki T, Kou K, Takahashi H, Saito T, Okubo N, Oishi M, Kakita A, Fujii Y. Meningoencephalocele in the lateral sphenoid sinus showing malformation of cortical development: A case report. NMC Case Reports, 9:281-287, 2022.
- 棗田学,温城太郎,渡邉潤,高橋陽彦,塚本佳広,岡田正康,平石哲也,吉村淳一,大石誠,藤井 幸彦.髄液よりH3K27M変異が検出可能なdiffuse midline gliomaの検討.小児の脳神経,47(4):1-7, 2022.(和)
- Saito S, Natsumeda M, Sainouchi M, Takino T, Shibuya K, On J, Kanemaru Y, Ogura R, Okada M, Oishi M, Shimada Y, Wakai T, Okuda S, Kakita A, Fujii Y. Elucidating the multiple genetic alterations involved in the malignant transformation of a KRAS mutant neurenteric cyst: A case report. Neuropathology, 42(6):519-525, 2022.
- Ota T, Ito Y, Shirozu H, Masuda H, Fukuda M, Tsukamoto Y, Natsumeda M, Oishi M, Fujii Y. Deep brain stimulation of the posterior subthalamic area and ventral intermediate nucleus via a single trajectory for severe symptomatic tremor: A case report. Functional Neurosurg, 61: 2022.(和)
- Sasame J, Ikegaya N, Kawazu M, Natsumeda M, Isoda M, Hayashi T, Satomi K, Tomiyama A, Oshima A, Honma H, Miyake Y, Takabayashi K, Nakamura T, Ueno T, Matsushita Y, Iwashita H, Kanemaru Y, Murata H, Ryo A, Terashima K, Yamanakata S, Fujii Y, Mano H, Komori T, Ichimura K, Cahill DP, Wakimoto H, Yamamoto T, Tateishi K. HSP90 inhibition overcomes resistance to molecular targeted therapy in BRAF V600E mutant glioblastoma. Clin Cancer Res, 28(11):2425-2439, 2022.
- Asano K, Yamashita Y, Ono T, Natsumeda M, Beppu T, Matsuda K, Ichikawa M, Kanamori M, Matsuzaka K, Kurose A, Fumoto T, Saito K, Sonoda Y, Ogasawara K, Fujii Y, Shimuzu H, Ohkuma H, Kitanaka C, Kayama T, Tominaga T. Clinicopathological risk factors for a poor prognosis of primary central nervous system lymphoma in elderly patients in the Tohoku and Niigata area: A multicenter, retrospective, cohort study of the Tohoku Brain Tumor Study Group.Brain Tumor Pathol, 39(3):139-150, 2022.
- 棗田学.悪性神経膠腫における免疫チェックポイント阻害療法: 現状と可能性.脳神経外科速報 32(2): 284-289, 2022.(和)
- Eda T, Okada M, Ogura R, Tsukamoto Y, Kanemaru Y, Watanabe J, On J, Aoki H, Oishi M, Takei N, Fujii Y, Natsumeda M. Novel repositioning therapy for drug-resistant glioblastoma: In vivo validation study of clindamycin treatment targeting the mTOR pathway and combination therapy with temozolomide. Cancers, 14(3): 770, 2022.
- Nakano M, Shimada Y, Matsumoto Y, Saiki T, Zou Q, Sasaki K, Moriyama M, Yoshihara K, Natsumeda M, Kuriyama Y, Takii Y, Watanabe G, Umezu H, Okuda S, Ikeuchi T, Wakai T, Saijo Y. Efficacy of BRAF inhibitor and anti-EGFR antibody in colorectal neuroendocrine carcinoma. Clin J Gastroenterol, 15(2):413-418, 2022.
- Ishi Y, Zhang Y, Zhang A, Sasaki T, Piunti A, Suri A, Watanabe J, Abe K, He X, Katagi H, Bhalla P, Natsumeda M, Zou L, Shilatifard A, Hashizume R. Therapeutic targeting of EZH2 and BET BRD4 in pediatric rhabdoid tumor. Mol Cancer Ther, 21(5):715-726, 2022.
- Mitsuhashi D, Hishida R, Oishi M, Hiraishi T, Natsumeda M, Shibuki K, Fujii Y. Visualization of cortical activation in human brain by flavoprotein fluorescence imaging. J Neurosurg, 137(4):1105-1113, 2022.
- Asano K, Yamashita Y, Ono T, Natsumeda M, Beppu T, Matsuda K, Ichikawa M, Kanamori M, Matsuzaka M, Kuraose A, Saito K, Sonoda Y, Ogasawara K, Fujii Y, Shimizu H, Ohkuma H, Kitanaka C, Kayama T, Tominaga T. The Real-World status and risk factors for a poor prognosis in elderly patients with primary central nervous system malignant lymphomas: a multicenter, retrospective cohort study of the Tohoku Brain Tumor Study Group. Int J Clin Oncol, 27(1):77-94, 2022.
- Ando K, Hiraishi T, Oishi M, Hasegawa H, Kikuchi B, Natsumeda M, Suzuki T, Saito S, Ota T, Yoshida Y, Fujii Y. Endovascular treatment of an infectious aneurysm using the selective provocative test and transcranial motor evoked potential monitoring under general anesthesia: a case report. Acta Neurochir (Wein), 164(5):1265-1269, 2022.
- Saito T, Jimbo Y, Takao T, Natsumeda M, Kawaguchi T. Choroid plexus papilloma in the fourth ventricle associated with pheochromocytoma: a case report. NMC Case Reports, 8(1):727-731, 2022.